Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Bibliographic Details
Main Authors: Boykin, C, Zhang, G, Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q
Format: Online
Language:English
Published: Nature Publishing Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/
id pubmed-3304433
recordtype oai_dc
spelling pubmed-33044332012-03-16 Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation Boykin, C Zhang, G Chen, Y-H Zhang, R-W Fan, X-E Yang, W-M Lu, Q Corrigendum Nature Publishing Group 2012-03-13 2012-03-13 /pmc/articles/PMC3304433/ http://dx.doi.org/10.1038/bjc.2012.77 Text en Copyright © 2012 Cancer Research UK
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
spellingShingle Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
author_facet Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
author_sort Boykin, C
title Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_short Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_full Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_fullStr Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_full_unstemmed Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_sort cucurbitacin iia: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of jak2/stat3 phosphorylation
description
publisher Nature Publishing Group
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/
_version_ 1611514263687397376

Similar Items